Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
$1.36
-17.3%
$2.50
$1.36
▼
$21.75
$5.93M1.4332,369 shs122,979 shs
ThredUp Inc. stock logo
TDUP
ThredUp
$1.58
+5.3%
$2.18
$1.24
▼
$8.76
$210.31M2.181.87 million shs1.65 million shs
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$4.10
-2.6%
$4.49
$3.45
▼
$7.30
$1.34B1.373.46 million shs2.47 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
0.00%-36.45%-40.09%-80.06%-92.12%
ThredUp Inc. stock logo
TDUP
ThredUp
0.00%+22.96%-32.77%-48.53%-80.57%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
0.00%-5.31%+9.92%-31.09%-5.96%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
$1.36
-17.3%
$2.50
$1.36
▼
$21.75
$5.93M1.4332,369 shs122,979 shs
ThredUp Inc. stock logo
TDUP
ThredUp
$1.58
+5.3%
$2.18
$1.24
▼
$8.76
$210.31M2.181.87 million shs1.65 million shs
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$4.10
-2.6%
$4.49
$3.45
▼
$7.30
$1.34B1.373.46 million shs2.47 million shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
0.00%-36.45%-40.09%-80.06%-92.12%
ThredUp Inc. stock logo
TDUP
ThredUp
0.00%+22.96%-32.77%-48.53%-80.57%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
0.00%-5.31%+9.92%-31.09%-5.96%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
1.67
Reduce$16.251,094.85% Upside
ThredUp Inc. stock logo
TDUP
ThredUp
2.57
Moderate Buy$4.64193.67% Upside
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.00
Buy$12.75210.98% Upside

Current Analyst Ratings Breakdown

Latest TSHA, TDUP, and PRPL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/5/2026
ThredUp Inc. stock logo
TDUP
ThredUp
DowngradeOutperform ➝ Market Perform
11/5/2026
ThredUp Inc. stock logo
TDUP
ThredUp
Lower Price TargetOverweight$8.00 ➝ $3.00
11/5/2026
ThredUp Inc. stock logo
TDUP
ThredUp
DowngradeOutperform ➝ Market Perform$2.00
11/3/2026
ThredUp Inc. stock logo
TDUP
ThredUp
UpgradeSell (E+) ➝ Sell (D-)
10/30/2026
ThredUp Inc. stock logo
TDUP
ThredUp
Initiated CoverageStrong-Buy
10/15/2026
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
Reiterated RatingSell (E+)
9/21/2026
ThredUp Inc. stock logo
TDUP
ThredUp
Reiterated RatingSell (E+)
9/21/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Reiterated RatingSell (D-)
9/17/2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
Initiated CoverageOutperform
(Data available from 11/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
$468.73M0.01N/AN/A($6.84) per share-0.20
ThredUp Inc. stock logo
TDUP
ThredUp
$310.81M0.68N/AN/A$0.47 per share3.36
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
$9.77M136.83N/AN/A$0.90 per share4.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
-$51.41M-$8.82N/AN/AN/A-8.90%N/A-12.13%N/A
ThredUp Inc. stock logo
TDUP
ThredUp
-$20.21M-$0.18N/AN/AN/A-6.89%-39.12%-13.81%N/A
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$109M-$0.42N/AN/AN/AN/A-51.87%-40.29%N/A

Latest TSHA, TDUP, and PRPL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
-$0.1286-$0.10+$0.0286-$0.10$0.76 millionN/A
11/4/2026Q3 2026
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
-$1.26-$2.41-$1.15-$0.33$105.72 million$96.51 million
11/4/2026Q3 2026
ThredUp Inc. stock logo
TDUP
ThredUp
-$0.0460-$0.04+$0.0060-$0.04$88.05 million$88.23 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
N/AN/AN/AN/AN/A
ThredUp Inc. stock logo
TDUP
ThredUp
N/AN/AN/AN/AN/A
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
N/A
0.47
0.22
ThredUp Inc. stock logo
TDUP
ThredUp
0.29
1.05
1.05
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
0.13
18.56
18.56

Institutional Ownership

CompanyInstitutional Ownership
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
88.41%
ThredUp Inc. stock logo
TDUP
ThredUp
89.08%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
77.70%

Insider Ownership

CompanyInsider Ownership
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
54.00%
ThredUp Inc. stock logo
TDUP
ThredUp
23.10%
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
3.48%
CompanyEmployeesShares OutstandingFree FloatOptionable
Purple Innovation, Inc. stock logo
PRPL
Purple Innovation
1,1004.36 million2.01 millionOptionable
ThredUp Inc. stock logo
TDUP
ThredUp
2,132133.11 million102.36 millionOptionable
Taysha Gene Therapies, Inc. stock logo
TSHA
Taysha Gene Therapies
99326.05 million314.70 millionOptionable

Recent News About These Companies

Taysha (TSHA) Q3 2026 Earnings Call Transcript
Taysha Gene Therapies Q3 Earnings Call Highlights
Taysha Gene Therapies' Q3 Net Loss Widens
Taysha Gene Therapies Reports Narrower Than Expected Loss for Q3 2026
Taysha Gene Therapies Q3 2026 earnings preview
Taysha Gene Therapies (TSHA) Stock Looks Rich Against Book Value

New MarketBeat Followers Over Time

Media Sentiment Over Time

Purple Innovation stock logo

Purple Innovation NASDAQ:PRPL

$1.36 -0.29 (-17.33%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$1.35 -0.01 (-0.74%)
As of 11/13/2026 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Purple Innovation, Inc. designs and manufactures sleep and other products in the United States and internationally. The company offers mattresses, pillows, cushions, bases, sheets, platforms, adjustable bases, mattress protectors, foundations, blankets, duvets, duvet covers, seat cushions, and pet beds under the Purple brand. It markets and sells its products through its e-commerce online channels, retail brick-and-mortar wholesale partners, third-party online retailers, and Purple showrooms, as well as through its website, Purple.com. The company was founded in 2010 and is headquartered in Lehi, Utah.

ThredUp stock logo

ThredUp NASDAQ:TDUP

$1.58 +0.08 (+5.33%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$1.55 -0.03 (-2.03%)
As of 11/13/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ThredUp Inc., together with its subsidiaries, operates an online resale platform in the United States and internationally. Its platform enables consumers to buy and sell primarily secondhand apparel, shoes, and accessories. ThredUp Inc. was incorporated in 2009 and is headquartered in Oakland, California.

Taysha Gene Therapies stock logo

Taysha Gene Therapies NASDAQ:TSHA

$4.10 -0.11 (-2.61%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$4.22 +0.12 (+2.93%)
As of 11/13/2026 05:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.